Dengue hemorrhagic fever (DHF) Dengue shock syndrome (DSS) Probable risk factors for DHF –the infecting virus’s strain/serotype –the age of the patient.

Slides:

Advertisements

Similar presentations

Urban Growth in Asian Cities Spread of dengue hemorrhagic fever in Asia.

Advertisements

Lecture Outline 1. Function of Introduction 2. Length 3. Parts 4. Examples How to write the introduction.

Genetics of longevity 1.Heritability Exceptional longevity (90+) a. appears to be a real category b. what is the basis? -reduced incidence.

2 Module 1 Pathophysiology Clinical course WHO classification & limitation Other manifestations Dr Suresh Kumar Infectious Diseases Unit Hospital Sungai.

III. Clinical Manifestations of Dengue and Dengue Hemorrhagic Fever CENTERS FOR DISEASE CONTROL AND PREVENTION.

Management of Dengue Fever Dr David Tran 16/09/09.

Dengue Hemorrhagic Fever Ms. Belton October 2014.

Dengue Fever By: Veroniqua Sanchez & Isaiah Lopez 1B.

DENGUE FEVER Amber Beg April 6, 2010 Biology 402

DENGUE: EPIDEMIOLOGY PART 1

Virus, Vector and Epidemiology

Common Viral Haemorrhagic Fevers include:  R R R Rift valley fever, Dengue fever, Lassa fever,.  E E E Ebola and marburg viral disease.  B B

Translational Control of Dengue Viral Genome: Role of 3’ UTR & CS1 Anna Carmona Mentor: Dr. Theo Dreher Assisted: Wei-Wei Chiu Department of Microbiology,

VIRAL HEAMORRHAGIC FEVERS Ahmed Mandil Prof of Epidemiology Dept of Family & Community Medicine College of Medicine, King Saud University.

TM Centers for Disease Control and Prevention National Center on Birth Defects and Developmental Disabilities Centers for Disease Control and Prevention.

The mechanism of ADE S 陳俊良. ADE has been proposed as an underlying pathogenic mechanism of DHF/ DSS. It often occurs in patients with second,

Case Study: Dengue Virus Virology 516 Fall 2007 Milette Mahinan, Suzi Sanchez, Olayinka Taiwo.

Dengue Seroepidemiology in India.

By: Students of Class 9th

Laboratory Investigation

DENGUE EPIDEMIOLOGY AND CONTROL PROGRAM IN MALAYSIA

Dr. Paramita Sengupta Department Of Community Medicine Christian Medical College Ludhiana Co-authors: Ragini Mann, Rohit Theodore, A I Benjamin Risk factors.

DENGUE & DENGUE HEMORRHAGIC FEVER Rab Chaudhry + Arzaan Shaikh.

Dengue Fever Guillermo Mata. Dengue fever also known as break bone fever, is an infectious tropical disease caused by the dengue virus.

OnSite Dengue Rapid Test.

Why do we care about it? What is Dengue? Is It Endemic In KSA? Infected Aedes mosquito Mode of Transmission ? Aim of the Study De ng ue Methodology Results.

DENGUE: EPIDEMIOLOGY PART II SCOTT B HALSTEAD, MD Director, Research PEDIATRIC DENGUE VACCINE INITIATIVE.

Dengue Virus Virus, Epidemiology (Aedes aegypti vector) Dengue Fever (DF) versus Dengue Hemorrhagic Fever (DHF) Hypothesis Plasma biomarkers exist that.

Part B Autoimmune Diseases Part B Autoimmune Diseases Effector mechanisms of autoimmune disease Endocrine glands as special targets.

Ward Audit: April Top 10 Diseases (comparing to previous month) April 2014March Pneumonia Pneumonia Acute Upper Respiratory.

VII. Treatment. Outpatient Triage n No hemorrhagic manifestations and patient is well-hydrated: home treatment n Hemorrhagic manifestations or hydration.

DENGUE idsurv data Presented by Dr S G Kasi Bengaluru.

Distribution of metabolic syndrome (MS) components by age and gender Zhao D, et al. Am J Cardiol 2007;100:835– 839.

In Taiwan Luke Huang & Jessica Leung.

Translational efficiency of Dengue Virus(DEN) and DEN variants in cells. Andrew Regan - Microbiology DREHER LAB - ALS1065.

311 com. Questions: DR.AWATIF ALAM. Questions ( 1 – 8 ) are about avian influenza A: 1- Infected birds shed virus in their: a.Saliva. b.nasal secretions.

FEVER DENGUE VIRUS: NO ONE IS SAFE Prepared by: Mohamed Abdul Gader.

Epidemiology and Biology of Dengue Fever Matthew Braswell BIOL 402 Spring 2014.

Dengue fever caused by dengue virus (DENV), a member of Flaviviridae leads to large global disease burden. Detection of immunoglobulin M (IgM) and nucleic.

Quick Insights on Some Viral Issues Dr. Haya Al-Tawalah Clinical Virologist.

RESULTS Division of Arboviruses, Center for Immunology and Pathology, National Institute of Health, Korea Centers for disease control, Osong, Korea BACKGROUND.

Dengue Hemorrhagic Fever: The Sensitivity and Specificity of the WHO Definition for Identification of Severe Cases of Dengue in Thailand, 1994–2005 R2.

EPIDEMIOLOGY OF INFNT DENGUE CASES ILLUMINATES SEROTYPE- SPECIFICITY IN THE INTERACTION BETWEEN IMMUNITY AND DISEASE AND CHANGES IN TRANSMISSION DYNAMICS.

Internal Medicine Workshop Series Laos September /October 2009

DENGUE FEVER Heshu Sulaiman Rahman December 2016

Multiple Alleles Human Blood Types.

CLINICAL PROFILE OF DENGUE FEVER

From: Clinical and Laboratory Diagnosis of Dengue Virus Infection

Copyright © 2017 American Academy of Pediatrics.

Líliam César de Castro Medeiros,

Laboratory diagnostics of dengue fever: An emphasis on the role of commercial dengue virus nonstructural protein 1 antigen rapid test Chung-Hao Huang,

FREQUENCIES AND PHENOTYPIC CHANGES OF DENDRITIC CELLS DURING ACUTE DENGUE VIRAL INFECTION Lertjuthaporn S1, Khowawisetsut L2, Keawvichit R1, Thitilertdecha.

Table 3. Comparison of NS1 Antigen Assay and Platelet Counts

Failures against ‘self’ (Principles of Autoimmunity)

Table 1 Dengue patient distribution according to clinical course and type of immune response From: Increment of interleukin 6, tumour necrosis factor alpha,

Dengue Eva Archer BIO 402.

Clinical Manifestations and Epidemiology

Dengue Prevention in Asia

V. Disease Pathogenesis

Dengue: A Global Threat

Dengue Virus Infections Investigation Guideline

Dr. Keerti Singh Assistant Professor SGRRITS

Celiac Disease Genetics: Current Concepts and Practical Applications

Genomic risk of hepatitis C-related hepatocellular carcinoma

Cases of travel-acquired dengue fever in Denmark 2001–2009

Challenges, Consideration, and Progress

Survival after HLA-Matched Sibling Donor HCT for ALL, Age ≥18 Years,

Presentation transcript:

Dengue hemorrhagic fever (DHF) Dengue shock syndrome (DSS) Probable risk factors for DHF –the infecting virus’s strain/serotype –the age of the patient –the genetic background of the patient

The distribution of each blood group among patients with DF was similar to that among patients with DHF. O B AAB

(39.1)(24.3)(29.7)(6.7)(43.7)(20.0)(30.6)(5.6) (50)(25) (43.9)(19.5)(31.7)(4.8) (33.3)(11.1)(44.4)(11.1)(38.2)(22.4)(34.8)(4.4) (100)(19.0)(9.5)(38.9)(33.3) (35.7)(14.2)(42.8)(7.1)(37.0)(19.8)(34.4)(8.6) (38.6)(22.7)(31.8)(6.8)(40.5)(19.9)(32.4)(7.0) (%) (by IgM/IgG ELISA)

(N-acetyl-D-galactosamine) (D-galactose) Glycoconjugate Journal (1997) 14:

A previous study of HLA and dengue-virus infection found that the infecting viral serotype influenced the strength of the association between specific HLA alleles and dengue- disease severity. Tissue Antigens 2002; 60:309–18. The results of the present study suggest that, when associated with a secondary infection, blood group AB may be a risk factor predisposing for severe dengue disease.